Hormone and breast cancer
Most of breast cancers are hormonedependent. Hormone treatment (contraception and menopause hormone treatment) has a promoter effect on preexisting lesions: the increase in risk decreases after stopping treatment. Hormonal contraception increases modestly the risk in current users but the amplitude...
Gespeichert in:
| Veröffentlicht in: | La Presse médicale (1983) 2019-10, Vol.48 (10), p.1085 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 10 |
| container_start_page | 1085 |
| container_title | La Presse médicale (1983) |
| container_volume | 48 |
| creator | Gompel, Anne |
| description | Most of breast cancers are hormonedependent. Hormone treatment (contraception and menopause hormone treatment) has a promoter effect on preexisting lesions: the increase in risk decreases after stopping treatment. Hormonal contraception increases modestly the risk in current users but the amplitude of the risk remains low up to 40 years when this increase is more significant due of the number of breast cancer occurring at that age. Pregnancy decreases the risk if at a young age but after 25 years may increase the risk. Combined menopause hormone treatment is associated to a greater risk than estrogens alone. Breast cancer associated with hormone treatment is estradiol receptor positive. There is an increase in the risk with duration. Combining the hormone treatment with an anti-estrogen could decrease the risk of breast cancer and help to keep the benefits of estrogens. |
| doi_str_mv | 10.1016/j.lpm.2019.09.021 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_31662219</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>31662219</sourcerecordid><originalsourceid>FETCH-LOGICAL-p178t-b07db29a8a505fcf591d400107e0efa8c3bd49acef707ce87262316ecb7c7aa33</originalsourceid><addsrcrecordid>eNo1jsFqwzAQREWhNGnaD8il-Afs7Eq21jqW0DaBQC7tOaykFTTEjpHTQ_4-hrYwMDAPZkapJUKFgHZ1rE5DV2lAV8EkjXdqrjWaEjTZmXocxyNMaU3uQc0MWjtBN1fLzTl3514K7mPhs_B4KQL3QfKTuk98GuX5zxfq6_3tc70pd_uP7fp1Vw5I7aX0QNFrxy030KSQGoexBkAgAUncBuNj7ThIIqAgLWmrp3kJngIxG7NQL7-9w4_vJB6G_N1xvh7-P5ob4zg71A</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hormone and breast cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Gompel, Anne</creator><creatorcontrib>Gompel, Anne</creatorcontrib><description>Most of breast cancers are hormonedependent. Hormone treatment (contraception and menopause hormone treatment) has a promoter effect on preexisting lesions: the increase in risk decreases after stopping treatment. Hormonal contraception increases modestly the risk in current users but the amplitude of the risk remains low up to 40 years when this increase is more significant due of the number of breast cancer occurring at that age. Pregnancy decreases the risk if at a young age but after 25 years may increase the risk. Combined menopause hormone treatment is associated to a greater risk than estrogens alone. Breast cancer associated with hormone treatment is estradiol receptor positive. There is an increase in the risk with duration. Combining the hormone treatment with an anti-estrogen could decrease the risk of breast cancer and help to keep the benefits of estrogens.</description><identifier>EISSN: 2213-0276</identifier><identifier>DOI: 10.1016/j.lpm.2019.09.021</identifier><identifier>PMID: 31662219</identifier><language>eng ; fre</language><publisher>France</publisher><subject>Age Factors ; Breast Neoplasms - etiology ; Breast Neoplasms - prevention & control ; Contraceptive Agents, Hormonal ; Estrogen Replacement Therapy - adverse effects ; Estrogens - adverse effects ; Female ; Humans ; Menopause ; Pregnancy</subject><ispartof>La Presse médicale (1983), 2019-10, Vol.48 (10), p.1085</ispartof><rights>Copyright © 2019 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31662219$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gompel, Anne</creatorcontrib><title>Hormone and breast cancer</title><title>La Presse médicale (1983)</title><addtitle>Presse Med</addtitle><description>Most of breast cancers are hormonedependent. Hormone treatment (contraception and menopause hormone treatment) has a promoter effect on preexisting lesions: the increase in risk decreases after stopping treatment. Hormonal contraception increases modestly the risk in current users but the amplitude of the risk remains low up to 40 years when this increase is more significant due of the number of breast cancer occurring at that age. Pregnancy decreases the risk if at a young age but after 25 years may increase the risk. Combined menopause hormone treatment is associated to a greater risk than estrogens alone. Breast cancer associated with hormone treatment is estradiol receptor positive. There is an increase in the risk with duration. Combining the hormone treatment with an anti-estrogen could decrease the risk of breast cancer and help to keep the benefits of estrogens.</description><subject>Age Factors</subject><subject>Breast Neoplasms - etiology</subject><subject>Breast Neoplasms - prevention & control</subject><subject>Contraceptive Agents, Hormonal</subject><subject>Estrogen Replacement Therapy - adverse effects</subject><subject>Estrogens - adverse effects</subject><subject>Female</subject><subject>Humans</subject><subject>Menopause</subject><subject>Pregnancy</subject><issn>2213-0276</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1jsFqwzAQREWhNGnaD8il-Afs7Eq21jqW0DaBQC7tOaykFTTEjpHTQ_4-hrYwMDAPZkapJUKFgHZ1rE5DV2lAV8EkjXdqrjWaEjTZmXocxyNMaU3uQc0MWjtBN1fLzTl3514K7mPhs_B4KQL3QfKTuk98GuX5zxfq6_3tc70pd_uP7fp1Vw5I7aX0QNFrxy030KSQGoexBkAgAUncBuNj7ThIIqAgLWmrp3kJngIxG7NQL7-9w4_vJB6G_N1xvh7-P5ob4zg71A</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Gompel, Anne</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>201910</creationdate><title>Hormone and breast cancer</title><author>Gompel, Anne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p178t-b07db29a8a505fcf591d400107e0efa8c3bd49acef707ce87262316ecb7c7aa33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; fre</language><creationdate>2019</creationdate><topic>Age Factors</topic><topic>Breast Neoplasms - etiology</topic><topic>Breast Neoplasms - prevention & control</topic><topic>Contraceptive Agents, Hormonal</topic><topic>Estrogen Replacement Therapy - adverse effects</topic><topic>Estrogens - adverse effects</topic><topic>Female</topic><topic>Humans</topic><topic>Menopause</topic><topic>Pregnancy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gompel, Anne</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>La Presse médicale (1983)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gompel, Anne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hormone and breast cancer</atitle><jtitle>La Presse médicale (1983)</jtitle><addtitle>Presse Med</addtitle><date>2019-10</date><risdate>2019</risdate><volume>48</volume><issue>10</issue><spage>1085</spage><pages>1085-</pages><eissn>2213-0276</eissn><abstract>Most of breast cancers are hormonedependent. Hormone treatment (contraception and menopause hormone treatment) has a promoter effect on preexisting lesions: the increase in risk decreases after stopping treatment. Hormonal contraception increases modestly the risk in current users but the amplitude of the risk remains low up to 40 years when this increase is more significant due of the number of breast cancer occurring at that age. Pregnancy decreases the risk if at a young age but after 25 years may increase the risk. Combined menopause hormone treatment is associated to a greater risk than estrogens alone. Breast cancer associated with hormone treatment is estradiol receptor positive. There is an increase in the risk with duration. Combining the hormone treatment with an anti-estrogen could decrease the risk of breast cancer and help to keep the benefits of estrogens.</abstract><cop>France</cop><pmid>31662219</pmid><doi>10.1016/j.lpm.2019.09.021</doi></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 2213-0276 |
| ispartof | La Presse médicale (1983), 2019-10, Vol.48 (10), p.1085 |
| issn | 2213-0276 |
| language | eng ; fre |
| recordid | cdi_pubmed_primary_31662219 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Age Factors Breast Neoplasms - etiology Breast Neoplasms - prevention & control Contraceptive Agents, Hormonal Estrogen Replacement Therapy - adverse effects Estrogens - adverse effects Female Humans Menopause Pregnancy |
| title | Hormone and breast cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T12%3A14%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hormone%20and%20breast%20cancer&rft.jtitle=La%20Presse%20m%C3%A9dicale%20(1983)&rft.au=Gompel,%20Anne&rft.date=2019-10&rft.volume=48&rft.issue=10&rft.spage=1085&rft.pages=1085-&rft.eissn=2213-0276&rft_id=info:doi/10.1016/j.lpm.2019.09.021&rft_dat=%3Cpubmed%3E31662219%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/31662219&rfr_iscdi=true |